Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019214 (hepatosplenomegaly)
 4,408 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The study was carried out on 2136 individuals from Abo El-Gohoor village. Their ages ranged from 1-72 years with a mean of 28.3 +/- 22.4 years. They were 46.7% males and 53.3% females. The village was divided into sectors. The inhabitants of each sector were examined clinically with history taking through home visits. Three successive stool samples for each individual were examined by the concentration technique. Abdominal ultrasound was done for hepatic and splenic assessment. Rectal biopsy was done for 200 subjects with negative stool samples for Schistosoma mansoni (S. mansoni) ova. Sex distribution was equal in this group. Their ages ranged from 18 to 45 years with a mean of 30.1 +/- 9.5 years. S. mansoni prevalence was 19.3% of individuals through stool examination and 12.5% out of 200 individuals with active schistosomiasis after rectal biopsy (the total prevalence was approximately 29.4%). Hepatic schistosomiasis was 18.8%. Hepatomegaly, hepatosplenomegaly, hepatic fibrosis without and with ascites were 6.0%, 8.8%, 2.5% and 1.5% of examined patients, respectively. The prevalence of intestinal parasites was 37.5% and 27.8% for E. histolytica and G. lamblia, respectively, 9.2% for H. nana, 6.2%, 9.6%, 2.4% and 1.5% for A. lumbricoides, E. vermicularis, T. trichura and A. duodenale, respectively and F. gigantica was 0.4%. A total of 84.6% of examined subjects had parasitic infestations, 60.2% had one parasite, 19.6% had 2 parasites, 4.2% had 3 parasites and 0.7% had 4 parasites. The study revealed some success of governmental efforts for control of schistosomiasis. The prevalence of S. mansoni through stool examination showed a prevalence lower than that reported before but which does not represent the actual prevalence of S. mansoni and rectal biopsy in addition gave more accurate results.
 ...
PMID:Prevalence of schistosoma mansoni and intestinal parasites with evaluation of hepatic schistosomiasis in a rural area after governmental efforts (Gharbia governorate). 1721 48

Visceral leishmaniasis (VL) is a neglected tropical disease that affects the poorest communities and can cause substantial morbidity and mortality. Visceral leishmaniasis is characterized by the presence of Leishmania parasites in the spleen, liver and bone marrow, hepatosplenomegaly, pancytopenia, prolonged fever, systemic inflammation and low body mass index (BMI). The factors impacting on the severity of VL are poorly characterized. Here we performed a cross-sectional study to assess whether co-infection of VL patients with intestinal parasites influences disease severity, assessed with clinical and haematological data, inflammation, cytokine profiles and BMI. Data from VL patients was similar to VL patients co-infected with intestinal parasites, suggesting that co-infection of VL patients with intestinal parasites does not alter disease severity.
 ...
PMID:Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites. 2873 17